Kyrmanidou, E. et al. 2024. A Real-Life 208 Week Single-Centred, Register-Based Retrospective Study Assessing Secukinumab Survival and Long-Term Efficacy and Safety Among Greek Patients With Moderate to Severe Plaque Psoriasis, Including Difficult-to-Treat Manifestations Such as Genitals and Scalp. Dermatology Practical & Conceptual. 14, 2 (Apr. 2024), e2024119. DOI:https://doi.org/10.5826/dpc.1402a119.